about
Leveraging the cortical cholinergic system to enhance attentionActivation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial culturesNicotine induced pro-oxidant and antioxidant imbalance in rat lymphocytes: in vivo dose and time dependent approachesCigarette smoking and cognitive function in Chinese male schizophrenia: a case-control studyEffect of nicotine on lung S-adenosylmethionine and development of Pneumocystis pneumonia.Cholinergic modulation of hippocampal activity during episodic memory encoding in postmenopausal women: a pilot studyModes and models of forebrain cholinergic neuromodulation of cognition.Pharmacokinetics and safety profile of ispronicline (TC-1734), a new brain nicotinic receptor partial agonist, in young healthy male volunteers.The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensationNicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older womenAcetylcholinergic neurotransmission and the beta-amyloid cascade: implications for Alzheimer's disease.Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics.Phasic acetylcholine release and the volume transmission hypothesis: time to move on.nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms.Nicotine and inflammatory neurological disorders.The potential of neuronal nicotinic acetylcholine receptor agonists for treating CNS conditions.Impact of Plant-Derived Flavonoids on Neurodegenerative Diseases.The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory.A pilot controlled trial of transdermal nicotine in the treatment of attention deficit hyperactivity disorder.A transgenic mouse model reveals fast nicotinic transmission in hippocampal pyramidal neuronsChronic nicotine treatment reverses hypothyroidism-induced impairment of L-LTP induction phase: critical role of CREB.Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.Cholinergic blockade under working memory demands encountered by increased rehearsal strategies: evidence from fMRI in healthy subjects.Central cholinergic system mediates working memory deficit induced by anesthesia/surgery in adult mice.
P2860
Q24598925-F08A6632-5270-428D-A813-4579C4FFF1CDQ24803737-5D7F4FBA-5F32-4C8B-A996-B58D50174E23Q28578479-927E82FD-3BD9-4D5A-9888-04171C07EF90Q28730147-055AD4CE-30C1-4012-86EE-F3B44E56A079Q31143306-D0F4EDCA-8637-470C-AED5-1F125567C1E8Q33984117-4DEB8A1B-E301-4890-909F-B608C6F4B9F9Q34355481-B84067C1-3380-4CF1-9C90-754724F24266Q34543205-82716F47-F8BD-432A-BC9E-5F964BA88800Q35042798-33FAABCB-9DD5-4C57-BC5E-E8774468D32DQ35043600-9418B6B6-60A4-4D26-B40A-B0878BC1112EQ36106834-5561C15B-F0A0-46AC-9EA3-562806DB1D6FQ37376724-015C8BDD-FBB3-4795-8FDB-0955B0BE4DC2Q37450800-002B0E6F-7CBF-4331-9A85-C5D1F457F689Q37465460-4091EA91-C72B-41EB-8A70-351AD29E1CAAQ37485944-F5460FE6-9576-462D-BD05-A6040F15DC40Q38090678-76D9B38D-802E-40D1-94F0-B89C1C1D0022Q38764212-AB0C0DB7-2ADA-4B41-A39E-79C7092EB706Q39016614-7C03E36D-61AD-4660-BA38-1BE230D386FCQ40616064-FE5ED428-D37F-4285-9807-C7BC9680BEA9Q41814452-FF4BD6F9-4DDB-40ED-8624-8AA7B0410C34Q44277952-EACA5CB4-E756-49F4-893F-8835FBF5B9E0Q44407158-57449DBB-2A14-4C19-A47B-8AD4B1982441Q48831751-99B7CB7C-329A-46FB-B408-9B1DBAB46912Q55264359-A8EE5B6E-A743-4E9E-BEAB-ADD5A9FDCDA4
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Nicotinic treatment of Alzheimer's disease.
@ast
Nicotinic treatment of Alzheimer's disease.
@en
type
label
Nicotinic treatment of Alzheimer's disease.
@ast
Nicotinic treatment of Alzheimer's disease.
@en
prefLabel
Nicotinic treatment of Alzheimer's disease.
@ast
Nicotinic treatment of Alzheimer's disease.
@en
P2093
P1476
Nicotinic treatment of Alzheimer's disease.
@en
P2093
P304
P356
10.1016/S0006-3223(00)01069-6
P407
P577
2001-02-01T00:00:00Z